MUSTACCHI, GIORGIO
 Distribuzione geografica
Continente #
EU - Europa 33
AS - Asia 4
Totale 37
Nazione #
IT - Italia 31
CN - Cina 3
FR - Francia 2
IN - India 1
Totale 37
Città #
Trieste 24
Beijing 3
Caivano 2
Bangalore 1
Venezia 1
Totale 31
Nome #
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies, file 2f47e97e-c0c1-46de-bc8a-01da0f561c4e 5
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study., file e2913fd9-eb4b-f688-e053-3705fe0a67e0 5
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer, file 7e535b6f-c5e9-4286-a912-28d00d81cc12 4
Valutazione quantitativa di Ki-67 nel carcinoma mammario: comparazione tra lettura al microscopio ottico e lettura con analizzatore automatico, file e2913fd9-1c3c-f688-e053-3705fe0a67e0 4
Identification and Validation of a New Set of Five Genes for Prediction of Risk in Early Breast Cancer, file e2913fd9-eb46-f688-e053-3705fe0a67e0 3
Cost-effectiveness and sustainability of breast cancer screening and new anti-cancer drugs, file e2913fdb-64cb-f688-e053-3705fe0a67e0 3
Advances in systemic therapy for metastatic breast cancer: future perspectives, file e2913fdb-94be-f688-e053-3705fe0a67e0 3
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies, file f2516945-4d43-480e-af7d-eea059db67cb 3
Corrigendum to "Gene expression profiling in breast cancer: A clinical perspective" [The Breast 22 (2013) 109-120 [doi:10.1016/j.breast.2013.01.016.]], file e2913fdb-6b2b-f688-e053-3705fe0a67e0 2
Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study. Biological characterization and selection criteria of adjuvant chemotherapy for early breast cancer: experience from the Italian observational NEMESI study, file e2913fd9-1473-f688-e053-3705fe0a67e0 1
Acneiform rash due to epidermal growth factor receptor inhibitors: high-level laser therapy as an innovative approach., file e2913fd9-1a29-f688-e053-3705fe0a67e0 1
Neo-adjuvant exemestane in elderly patients with breast cancer: a phase II, multicentre, open-label, Italian study, file e2913fd9-1f7e-f688-e053-3705fe0a67e0 1
Increased overall survival independent of RECIST response in metastatic breast cancer patients continuing trastuzumab treatment: evidence from a retrospective study., file e2913fdb-a4f3-f688-e053-3705fe0a67e0 1
Erratum to: Advances in systemic therapy for metastatic breast cancer: future perspectives (Medical Oncology, (2017), 34, 7, (119), 10.1007/s12032-017-0975-5), file e2913fdc-85f5-f688-e053-3705fe0a67e0 1
Totale 37
Categoria #
all - tutte 94
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 1 0 0 0 0
2020/20211 0 0 1 0 0 0 0 0 0 0 0 0
2023/202412 0 7 0 0 0 0 0 5 0 0 0 0
Totale 37